Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 8, 2015- ELIXA is the first event-driven cardiovascular outcomes study to provide data for a GLP-1 receptor agonist -
-
May 21, 2015- Includes study in patients who were inadequate responders to, or intolerant of, TNF-alpha inhibitors -